We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 707

German perspective on new EU clinical trials regulation
  • McDermott Will & Emery
  • Germany
  • October 29 2014

On June 16 2014 EU Regulation 5362014 on Clinical Trials on Medicinal Products for Human Use entered into force. Once it becomes applicable, the


Associations calls for better protection of consumers in draft law on e-health
  • Squire Patton Boggs
  • Germany
  • March 23 2015

The Federation of German Consumer Organisations (Vebraucherzentrale Bundesverband (VZBV)) recently criticized the new draft law on e-health stating


Connected health: legal aspects of health apps in Germany
  • Taylor Wessing
  • Germany
  • April 20 2015

In the near future, your smartphone may act as a "portable GP": Analysing the data from a wireless sensor patch on your body to warn you about your


World Obesity Federation conference to target Dietary Sugars and Metabolic Disease Risk
  • Shook Hardy & Bacon LLP
  • Germany
  • March 20 2015

The World Obesity Federation is convening clinicians, researchers and policymakers in Berlin, Germany, for a June 29-30, 2015, conference titled


Horizonte 2015
  • Norton Rose Fulbright LLP
  • European Union, Germany
  • February 11 2015

Seit Mitte 2013 können wir durch unsere Präsenz auch im US-amerikanischen Markt ein globales Profil anbieten, das den vielfältigen Anforderungen


International news: focus on compliance - winter 2014
  • McDermott Will & Emery
  • China, European Union, Germany, Global, USA
  • December 2 2014

As regulatory oversight of companiesfrom Sarbanes Oxley and the Dodd-Frank Act to the Foreign Corrupt Practices Act (FCPA) and the UK Bribery


A German perspective on pharmaceutical protection
  • Meissner Bolte & Partner
  • Germany
  • December 20 2013

According to information available from the Federal Ministry of Economics and Technology website, for many years the Germany pharmaceutical industry


German court re-enforces incentives ban against manufacturer: no touchpads for increased sales
  • Jones Day
  • Germany
  • December 6 2012

Medical device manufacturers whose products more closely resemble consumer goods may be inclined to lose sight of German health care compliance legislation


A consistently broad interpretation of "health claim" emerges in Europe
  • Taylor Wessing
  • European Union, Germany
  • April 30 2014

A decision recently handed down by the German Federal Court of Justice (Bundesgerichtshof - BGH) has confirmed the broad interpretation of the term


Akute Auswirkungen Entscheidung Betreffend Deskriptive Zusätze zu Arzneimittelbezeichnungen
  • Latham & Watkins LLP
  • Germany
  • August 8 2013

Das Oberverwaltungsgericht Nordrhein-Westfalen (OVG-NRW) hat ein Urteil des Verwaltungsgerichts Köln (VG Köln) aufrecht erhalten, nach welchem ein